Prestige Consumer Healthcare Inc. Stock
The Prestige Consumer Healthcare Inc. stock is trending slightly upwards today, with an increase of €0.50 (0.880%) compared to yesterday's price.
Currently there is a rather positive sentiment for Prestige Consumer Healthcare Inc. with 3 Buy predictions and 0 Sell predictions.
With a target price of 64 € there is a slightly positive potential of 11.3% for Prestige Consumer Healthcare Inc. compared to the current price of 57.5 €.
Pros and Cons of Prestige Consumer Healthcare Inc. in the next few years
Pros
?
B****
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
C******** o* t** e**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Prestige Consumer Healthcare Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Prestige Consumer Healthcare Inc. | 0.880% | -0.862% | 8.491% | -27.215% | 7.477% | 0.877% | 63.352% |
| Apollo Medical Holdings, Inc. | 2.330% | 1.190% | -9.091% | -48.795% | -19.811% | -50.292% | - |
| Petmed Express Inc | 1.770% | -3.731% | -12.876% | -45.230% | -18.642% | -86.564% | -91.533% |
| Suzuken Co Ltd | -1.140% | 4.142% | 5.389% | 40.800% | 7.317% | 40.800% | 11.392% |
Comments
Prestige Consumer Healthcare (NYSE:PBH) had its price target lowered by analysts at Oppenheimer Holdings, Inc. from $82.00 to $72.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for PBH provided by MarketBeat
Prestige Consumer Healthcare (NYSE:PBH) was upgraded by analysts at Sidoti from a "neutral" rating to a "buy" rating. They now have a $80.00 price target on the stock.
Show more
Ratings data for PBH provided by MarketBeat
Prestige Consumer Healthcare Inc. (NYSE: PBH) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for PBH provided by MarketBeat